12:00 AM
 | 
Apr 16, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Neurotune AG

Zurich, Switzerland

Technology: Neurotrypsin inhibitors

Disease focus: Sarcopenia

Clinical status: Preclinical

Founded: 2005 by...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >